PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-Nov-2022 Blaze Bioscience Announces Enrollment is Complete on its Pivotal Phase 2/3 Trial of tozuleristide and the CanvasTM Imaging System in Pediatric Central Nervous System Tumors Businesswire
02-Nov-2022 Can-Fite: Positive New Data from it’s Phase III Psoriasis Study will be Presented Today at an Industry Expert Summit in Boston Businesswire
02-Nov-2022 2022 China Crop Protection China Monthly Report: Stay Ahead in the Fast-Changing Market With Real-Time Reporting on the Whole Industrial Chain - ResearchAndMarkets.com Businesswire
02-Nov-2022 Precision BioSciences to Report Third Quarter 2022 Financial Results on November 8, 2022 Businesswire
02-Nov-2022 BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Marginal Zone Lymphoma Businesswire
02-Nov-2022 KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Businesswire
02-Nov-2022 Redwire Launching Upgraded 3D Bioprinter to Space Station to Investigate New Treatment to Aid Military Service Members, Expands Crop Production Research and Materials Testing on Orbit Businesswire
02-Nov-2022 Charles River Laboratories Announces Third-Quarter 2022 Results Businesswire
02-Nov-2022 GlycoMimetics to Report Third Quarter Financial Results on November 9, 2022 Businesswire
02-Nov-2022 Sense and Biotecom Agree to Distribute Rapid, Instrument-Free Molecular Test, Veros COVID-19 in Chile Businesswire
02-Nov-2022 OmniAb, Inc. to Ring Nasdaq Stock Market Opening Bell Businesswire
02-Nov-2022 Antibe Closes Previously Announced Strategic Sale of Citagenix Subsidiary Businesswire
02-Nov-2022 Data Reinforcing Impact of Bristol Myers Squibb Cardiovascular Portfolio to be Presented at American Heart Association Scientific Sessions 2022 Businesswire
02-Nov-2022 ROME Therapeutics and Enara Bio to Host Inaugural Dark Genome Symposium Convening Industry and Academic Leaders to Catalyze Therapeutic Application of Dark Genome Research Businesswire
02-Nov-2022 Lusaris Therapeutics Launches with $60 Million Series A Financing to Redefine the Treatment of Severe Neuropsychiatric and Neurological Disorders Businesswire
02-Nov-2022 Global Cannabis Testing Market to Grow at 16.5% Annually Through 2029 - ResearchAndMarkets.com Businesswire
02-Nov-2022 Transdermal Drug Delivery Market Analysis 2022: Technological Advances Present Lucrative Opportunities - ResearchAndMarkets.com Businesswire
02-Nov-2022 CureApp: Digital Therapeutic App for Hypertension Receives Insurance Coverage, Sales of the Service to Medical Institutions Across Japan Launch on September 1 Businesswire
02-Nov-2022 L&T Technology Services Inaugurates Engineering R&D Center in Toronto, Canada Businesswire
02-Nov-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire